PUBLIC DISCLOSURE & CLARIFICATION

BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.

CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.

9-(2'-O-Acetyl-5'-O-benzoyl-3'-deoxy-beta-D-ribofuranosyl)-6-chloropurine

Inquiry

Cat. No.: X25-06-LY506

9-(2'-O-Acetyl-5'-O-benzoyl-3'-deoxy-beta-D-ribofuranosyl)-6-chloropurine

Synonym: 1347118-41-5; [(2S,4R,5R)-4-Acetyloxy-5-(6-chloropurin-9-yl)oxolan-2-yl]methyl benzoate; ((2S,4R,5R)-4-Acetoxy-5-(6-chloro-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl benzoate; [(2S,4R,5R)-4-(Acetyloxy)-5-(6-chloro-9H-purin-9-yl)oxolan-2-yl]methyl benzoate; (5S,2R,3R)-2-(6-Chloropurin-9-yl)-5-(phenylcarbonyloxymethyl)oxolan-3-yl acetate

CAS Number: 1347118-41-5
Compound CID: 86594480

Product Size

50 mg; 100 mg; 250 mg; 500 mg

Price

Datasheet

MSDS

Properties

Description

9-(2'-O-Acetyl-5'-O-benzoyl-3'-deoxy-beta-D-ribofuranosyl)-6-chloropurine is a modified chloropine derivative that can be used in molecular design and synthetic biology.

Molecular Weight

416.82

Molecular Formula

C₁₉H₁₇ClN₄O₅

Form

Solid

Purity

≥95.0%

Applications

9-(2'-O-Acetyl-5'-O-benzoyl-3'-deoxy-beta-D-ribofuranosyl)-6-chloropurine can be used in drug research and development and as an intermediate for nucleic acid synthesis.

Publications

Publications (0)

Publications

Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.